Ciloa
Ciloa is a pioneer in the bioengineering of extracellular vesicles to develop new generations of therapeutics and preventive solutions to improve patients' lives.
Ciloa has raised €6.5M across 1 funding round from 3 investors, most recently a round in Jul 2025. Based in Montpellier, France; active in Healthtech. Data as of 28 Oct 2026.
Montpellier, Francewww.ciloa.bio ↗
Total raised
€6.5M
€6,500,000
Funding rounds
1
Investors
3
distinct backers
Active since
2025-07
latest 2025-07
Funding by year
EUR raised per yearCiloa — funding by year — interactive chart.
Data table
| Ciloa — funding by year | |
|---|---|
| 2025 | €6.5M |
Signals
High confidenceRaise-next likelihood43
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-09 | Other | €6.5M | Bpifrance,France 2030 ‘Biotherapies and Biomanufacturing of Innovative Therapies’,French Government | View deal → |
Investors
3Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData